Loading...
Jeremiah Metzger Lecture. Targeted cancer therapy.
I have reviewed here and elsewhere the preclinical data and the clinical trials which have demonstrated the efficacy of therapy with monoclonal antibodies that block activation of receptors for growth factors (12). Herceptin is now in clinical use. Our own antibody, C225 against the EGF receptor, sh...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Clinical and Climatological Association
2000
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2194374/ https://ncbi.nlm.nih.gov/pubmed/10881335 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|